Engineered Repeat Protein Hybrids: The New Horizon for Biologic Medicines and Diagnostic Tools

Abstract

Conspectus The last decades have witnessed unprecedented scientific breakthroughs in all the fields of knowledge, from basic sciences to translational research, resulting in the drastic improvement of the lifespan and overall quality of life. However, despite these great advances, the treatment and diagnosis of some diseases remain a challenge. Inspired by nature, scientists have been exploring biomolecules and their derivatives as novel therapeutic/diagnostic agents. Among biomolecules, proteins raise much interest due to their high versatility, biocompatibility, and biodegradability. Protein binders (binders) are proteins that bind other proteins, in certain cases, inhibiting or modulating their action. Given their therapeutic potential, binders are emerging as the next generation of biopharmaceuticals. The most well-known example of binders are antibodies, and inspired by them researchers have developed alternative binders using protein design approaches. Protein design can be based on naturally occurring proteins in which, by means of rational design or combinatorial approaches, new binding interfaces can be engineered to obtain specific functions or based on de novo proteins emerging from state-of-the-art computational methodologies. Among the novel designed proteins, a class of engineered repeat proteins, the consensus tetratricopeptide repeat (CTPR) proteins, stand out due to their stability and robustness. The CTPR unit is a helix-turn-helix motif constituted of 34 amino acids, of which only 8 are essential to ensure correct folding of the structure. The small number of conserved residues of CTPR proteins leaves plenty of freedom for functional mutations, making them a base scaffold that can be easily and reproducibly tailored to endow desired functions to the protein. For example, the introduction of metal-binding residues (e.g., histidines, cysteines) drives the coordination of metal ions and the subsequent formation of nanomaterials. Additionally, the CTPR unit can be conjugated with other peptides/proteins or repeated in tandem to encode larger CTPR proteins with superhelical structures. These properties allow for the design of both binder and nanomaterial-coordination modules as well as their combination within the same molecule, making the CTPR proteins, as we have demonstrated in several recent examples, the ideal platform to develop protein–nanomaterial hybrids. Generally, the fusion of two distinct materials exploits the best properties of each; however, in protein–nanomaterial hybrids, the fusion takes on a new dimension as new properties arise. These hybrids have ushered the use of protein-based nanomaterials as biopharmaceuticals beyond their original therapeutic scope and paved the way for their use as theranostic agents. Despite several reports of protein-stabilized nanomaterials found in the literature, these systems offer limited control in the synthesis and properties of the grown nanomaterials, as the protein acts just as a stabilizing agent with no significant functional contribution. T...

Engineered Protein-Driven Synthesis of Tunable Iron Oxide Nanoparticles as T1 and T2 Magnetic Resonance Imaging Contrast Agents

“…The integrity of the protein scaffold after the synthesis of Prot-IONPs, which is the key for biomedical applications, , was verified by circular dichroism (CD). The CD spectra of the protein scaffolds presented the characteristic signature of well folded α-helical structures (Figure S4).…”

Broadening Approaches in Nanoparticle Synthesis Through Elastin-Like Polypeptides

“…As presented before, this methodology is not only capable to address the stabilization of the nanoparticles but also their biocompatibility, which is a major concern in the use of some heavy metal nanoparticles in biomedical field. Furthermore, the control of NP size and its properties has been done already with peptides or engineered proteins (Li et al, 2021;Uribe et al, 2021). These strategies reveal how guest residues as tyrosine, cysteine or tryptophan are capable to drive reduction, condensation or coordination of species that guide the formation of 1D nanostructures, as well as NPs stabilization.…”

Engineered flavoproteins as bioorthogonal photo-triggers for the activation of metal-based anticancer prodrugs

“…2 Only 8 residues have a key structural role to define the CTPR fold, hence leaving plenty of room for introducing sequence mutations capable of conferring diverse chemical and biological functions. 2 CTPRs have been shown to be robust platforms for the generation of systems that allow the templating of gold nanoparticles, 9 metallic nanoclusters, 10 redox active clusters, 11 carbon nanotubes and porphyrins, 12 among others. These hybrids have so far been studied for applications such as electroconductivity, 13 optics 14,15 catalysis and theranostics.…”

“…In contrast, antibodies suffer from several disadvantages including high production and storage costs, limited stability, and low batch-to-batch reproducibility. 2…”

“…Multifunctional hybrids 1 constructed by biomolecular templating are structures capable of performing complex activities depending on the nature of each component. 2 They are generally composed of a biomolecule that, mimicking the natural scaffolds, [3][4][5] displays multiple elements with a defined organization. Proteins are the most widely used templates, and in particular repeat proteins, since their repeated modular nature makes them ideal scaffolds for engineering.…”